Pumps like P-glycoprotein can lead to drug resistance by expelling therapeutic drugs from cells, reducing their efficacy. This is particularly significant in cancer treatment, where overactive efflux pumps can lead to multidrug resistance, making it challenging to treat tumors effectively.
